Cargando…

Ligamentum teres hepatis as a graft for portal and/or superior mesenteric vein reconstruction: From bench to bedside

BACKGROUND: Pancreaticoduodenectomy combined with portal vein (PV) and/or superior mesenteric vein (SMV) resection in patients with pancreaticobiliary malignancy has become a common surgical procedure. There are various grafts currently used for PV and/or SMV reconstruction, but each of these grafts...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Wen-Tao, Wang, Hai-Tao, Guan, Qing-Hai, Zhang, Fan, Zhang, Chang-Xi, Hu, Feng-Ai, Zhao, Bao-Lei, Zhou, Lei, Wei, Qiang, Ji, Hai-Bin, Fu, Ting-Liang, Zhang, Xing-Yuan, Wang, Rui-Tao, Chen, Qiang-Pu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10190722/
https://www.ncbi.nlm.nih.gov/pubmed/37206073
http://dx.doi.org/10.4240/wjgs.v15.i4.674
_version_ 1785043332095803392
author Zhu, Wen-Tao
Wang, Hai-Tao
Guan, Qing-Hai
Zhang, Fan
Zhang, Chang-Xi
Hu, Feng-Ai
Zhao, Bao-Lei
Zhou, Lei
Wei, Qiang
Ji, Hai-Bin
Fu, Ting-Liang
Zhang, Xing-Yuan
Wang, Rui-Tao
Chen, Qiang-Pu
author_facet Zhu, Wen-Tao
Wang, Hai-Tao
Guan, Qing-Hai
Zhang, Fan
Zhang, Chang-Xi
Hu, Feng-Ai
Zhao, Bao-Lei
Zhou, Lei
Wei, Qiang
Ji, Hai-Bin
Fu, Ting-Liang
Zhang, Xing-Yuan
Wang, Rui-Tao
Chen, Qiang-Pu
author_sort Zhu, Wen-Tao
collection PubMed
description BACKGROUND: Pancreaticoduodenectomy combined with portal vein (PV) and/or superior mesenteric vein (SMV) resection in patients with pancreaticobiliary malignancy has become a common surgical procedure. There are various grafts currently used for PV and/or SMV reconstruction, but each of these grafts have certain limitations. Therefore, it is necessary to explore novel grafts that have an extensive resource pool, are low cost with good clinical application, and are without immune response rejection or additional damage to patients. AIM: To observe the anatomical and histological characteristics of the ligamentum teres hepatis (LTH) and evaluate PV/SMV reconstruction using an autologous LTH graft in pancreaticobiliary malignancy patients. METHODS: In 107 patients, the post-dilated length and diameter in resected LTH specimens were measured. The general structure of the LTH specimens was observed by hematoxylin and eosin (HE) staining. Collagen fibers (CFs), elastic fibers (EFs), and smooth muscle (SM) were visualized by Verhoeff-Van Gieson staining, and the expression of CD34, factor VIII-related antigen (FVIIIAg), endothelial nitric oxide synthase (eNOS), and tissue type plasminogen activator (t-PA) were detected using immunohistochemistry in LTH and PV (control) endothelial cells. PV and/or SMV reconstruction using the autologous LTH was conducted in 26 patients with pancreaticobiliary malignancies, and the outcomes were retrospectively analyzed. RESULTS: The post-dilated length of LTH was 9.67 ± 1.43 cm, and the diameter at a pressure of 30 cm H(2)O was 12.82 ± 1.32 mm at the cranial end and 7.06 ± 1.88 mm at the caudal end. Residual cavities with smooth tunica intima covered by endothelial cells were found in HE-stained LTH specimens. The relative amounts of EFs, CFs and SM in the LTH were similar to those in the PV [EF (%): 11.23 ± 3.40 vs 11.57 ± 2.80, P = 0.62; CF (%): 33.51 ± 7.71 vs 32.11 ± 4.82, P = 0.33; SM (%): 15.61 ± 5.26 vs 16.74 ± 4.83, P = 0.32]. CD34, FVIIIAg, eNOS, and t-PA were expressed in both LTH and PV endothelial cells. The PV and/or SMV reconstructions were successfully completed in all patients. The overall morbidity and mortality rates were 38.46% and 7.69%, respectively. There were no graft-related complications. The postoperative vein stenosis rates at 2 wk, 1 mo, 3 mo and 1 year were 7.69%, 11.54%, 15.38% and 19.23%, respectively. In all 5 patients affected, the degree of vascular stenosis was less than half of the reconstructed vein lumen diameter (mild stenosis), and the vessels remained patent. CONCLUSION: The anatomical and histological characteristics of LTH were similar to the PV and SMV. As such, the LTH can be used as an autologous graft for PV and/or SMV reconstruction in pancreaticobiliary malignancy patients who require PV and/or SMV resection.
format Online
Article
Text
id pubmed-10190722
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-101907222023-05-18 Ligamentum teres hepatis as a graft for portal and/or superior mesenteric vein reconstruction: From bench to bedside Zhu, Wen-Tao Wang, Hai-Tao Guan, Qing-Hai Zhang, Fan Zhang, Chang-Xi Hu, Feng-Ai Zhao, Bao-Lei Zhou, Lei Wei, Qiang Ji, Hai-Bin Fu, Ting-Liang Zhang, Xing-Yuan Wang, Rui-Tao Chen, Qiang-Pu World J Gastrointest Surg Observational Study BACKGROUND: Pancreaticoduodenectomy combined with portal vein (PV) and/or superior mesenteric vein (SMV) resection in patients with pancreaticobiliary malignancy has become a common surgical procedure. There are various grafts currently used for PV and/or SMV reconstruction, but each of these grafts have certain limitations. Therefore, it is necessary to explore novel grafts that have an extensive resource pool, are low cost with good clinical application, and are without immune response rejection or additional damage to patients. AIM: To observe the anatomical and histological characteristics of the ligamentum teres hepatis (LTH) and evaluate PV/SMV reconstruction using an autologous LTH graft in pancreaticobiliary malignancy patients. METHODS: In 107 patients, the post-dilated length and diameter in resected LTH specimens were measured. The general structure of the LTH specimens was observed by hematoxylin and eosin (HE) staining. Collagen fibers (CFs), elastic fibers (EFs), and smooth muscle (SM) were visualized by Verhoeff-Van Gieson staining, and the expression of CD34, factor VIII-related antigen (FVIIIAg), endothelial nitric oxide synthase (eNOS), and tissue type plasminogen activator (t-PA) were detected using immunohistochemistry in LTH and PV (control) endothelial cells. PV and/or SMV reconstruction using the autologous LTH was conducted in 26 patients with pancreaticobiliary malignancies, and the outcomes were retrospectively analyzed. RESULTS: The post-dilated length of LTH was 9.67 ± 1.43 cm, and the diameter at a pressure of 30 cm H(2)O was 12.82 ± 1.32 mm at the cranial end and 7.06 ± 1.88 mm at the caudal end. Residual cavities with smooth tunica intima covered by endothelial cells were found in HE-stained LTH specimens. The relative amounts of EFs, CFs and SM in the LTH were similar to those in the PV [EF (%): 11.23 ± 3.40 vs 11.57 ± 2.80, P = 0.62; CF (%): 33.51 ± 7.71 vs 32.11 ± 4.82, P = 0.33; SM (%): 15.61 ± 5.26 vs 16.74 ± 4.83, P = 0.32]. CD34, FVIIIAg, eNOS, and t-PA were expressed in both LTH and PV endothelial cells. The PV and/or SMV reconstructions were successfully completed in all patients. The overall morbidity and mortality rates were 38.46% and 7.69%, respectively. There were no graft-related complications. The postoperative vein stenosis rates at 2 wk, 1 mo, 3 mo and 1 year were 7.69%, 11.54%, 15.38% and 19.23%, respectively. In all 5 patients affected, the degree of vascular stenosis was less than half of the reconstructed vein lumen diameter (mild stenosis), and the vessels remained patent. CONCLUSION: The anatomical and histological characteristics of LTH were similar to the PV and SMV. As such, the LTH can be used as an autologous graft for PV and/or SMV reconstruction in pancreaticobiliary malignancy patients who require PV and/or SMV resection. Baishideng Publishing Group Inc 2023-04-27 2023-04-27 /pmc/articles/PMC10190722/ /pubmed/37206073 http://dx.doi.org/10.4240/wjgs.v15.i4.674 Text en ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
spellingShingle Observational Study
Zhu, Wen-Tao
Wang, Hai-Tao
Guan, Qing-Hai
Zhang, Fan
Zhang, Chang-Xi
Hu, Feng-Ai
Zhao, Bao-Lei
Zhou, Lei
Wei, Qiang
Ji, Hai-Bin
Fu, Ting-Liang
Zhang, Xing-Yuan
Wang, Rui-Tao
Chen, Qiang-Pu
Ligamentum teres hepatis as a graft for portal and/or superior mesenteric vein reconstruction: From bench to bedside
title Ligamentum teres hepatis as a graft for portal and/or superior mesenteric vein reconstruction: From bench to bedside
title_full Ligamentum teres hepatis as a graft for portal and/or superior mesenteric vein reconstruction: From bench to bedside
title_fullStr Ligamentum teres hepatis as a graft for portal and/or superior mesenteric vein reconstruction: From bench to bedside
title_full_unstemmed Ligamentum teres hepatis as a graft for portal and/or superior mesenteric vein reconstruction: From bench to bedside
title_short Ligamentum teres hepatis as a graft for portal and/or superior mesenteric vein reconstruction: From bench to bedside
title_sort ligamentum teres hepatis as a graft for portal and/or superior mesenteric vein reconstruction: from bench to bedside
topic Observational Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10190722/
https://www.ncbi.nlm.nih.gov/pubmed/37206073
http://dx.doi.org/10.4240/wjgs.v15.i4.674
work_keys_str_mv AT zhuwentao ligamentumtereshepatisasagraftforportalandorsuperiormesentericveinreconstructionfrombenchtobedside
AT wanghaitao ligamentumtereshepatisasagraftforportalandorsuperiormesentericveinreconstructionfrombenchtobedside
AT guanqinghai ligamentumtereshepatisasagraftforportalandorsuperiormesentericveinreconstructionfrombenchtobedside
AT zhangfan ligamentumtereshepatisasagraftforportalandorsuperiormesentericveinreconstructionfrombenchtobedside
AT zhangchangxi ligamentumtereshepatisasagraftforportalandorsuperiormesentericveinreconstructionfrombenchtobedside
AT hufengai ligamentumtereshepatisasagraftforportalandorsuperiormesentericveinreconstructionfrombenchtobedside
AT zhaobaolei ligamentumtereshepatisasagraftforportalandorsuperiormesentericveinreconstructionfrombenchtobedside
AT zhoulei ligamentumtereshepatisasagraftforportalandorsuperiormesentericveinreconstructionfrombenchtobedside
AT weiqiang ligamentumtereshepatisasagraftforportalandorsuperiormesentericveinreconstructionfrombenchtobedside
AT jihaibin ligamentumtereshepatisasagraftforportalandorsuperiormesentericveinreconstructionfrombenchtobedside
AT futingliang ligamentumtereshepatisasagraftforportalandorsuperiormesentericveinreconstructionfrombenchtobedside
AT zhangxingyuan ligamentumtereshepatisasagraftforportalandorsuperiormesentericveinreconstructionfrombenchtobedside
AT wangruitao ligamentumtereshepatisasagraftforportalandorsuperiormesentericveinreconstructionfrombenchtobedside
AT chenqiangpu ligamentumtereshepatisasagraftforportalandorsuperiormesentericveinreconstructionfrombenchtobedside